2011
DOI: 10.1016/j.drudis.2011.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
55
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 77 publications
(59 citation statements)
references
References 65 publications
3
55
1
Order By: Relevance
“…Hypoxia-induced OS causes the EMR of myocardial cells and brain cells in ischemic diseases including myocardial or cerebral infarction. Loss of function of ATM leads to the inhibition of the insulin pathway, insulin resistance, and decrease of glucose uptake [94,95]. So, based on the facts that the EMR was observed in the CAFs and oxidized ATM was widely involved in the cellular glucose metabolism, we guess that ATM may also be a key regulator of the CAFs' EMR.…”
Section: The Redox Sensor Atm and Cellular Emrmentioning
confidence: 99%
See 1 more Smart Citation
“…Hypoxia-induced OS causes the EMR of myocardial cells and brain cells in ischemic diseases including myocardial or cerebral infarction. Loss of function of ATM leads to the inhibition of the insulin pathway, insulin resistance, and decrease of glucose uptake [94,95]. So, based on the facts that the EMR was observed in the CAFs and oxidized ATM was widely involved in the cellular glucose metabolism, we guess that ATM may also be a key regulator of the CAFs' EMR.…”
Section: The Redox Sensor Atm and Cellular Emrmentioning
confidence: 99%
“…Under the condition of insulin stimulus, the active AKT is responsible for GLUT4 translocation from the cytosol to the plasma membrane and glucose uptake in muscle cells [94]. The mTORC1 signaling pathway is a most frequently dysregulated signaling cascade in cancers resulting from activation of proto-oncogenes and loss of tumor suppressors.…”
Section: The Pi3k/akt/mtorc1 Pathwaymentioning
confidence: 99%
“…The disease affects 1 in 40 000 to 1 in 200 000 individuals globally, with an estimated 2.8 % of the global population being A-T carriers [3,4]. The most prominent characteristics of A-T are cerebellar neurodegeneration, oculocutaneous telangiectasia, immunodeficiency, a high risk for cancer, premature ageing and radiosensitivity [2,5,6]. Patients also display growth retardation, insulin resistance and glucose intolerance [6].…”
Section: Introductionmentioning
confidence: 99%
“…The most prominent characteristics of A-T are cerebellar neurodegeneration, oculocutaneous telangiectasia, immunodeficiency, a high risk for cancer, premature ageing and radiosensitivity [2,5,6]. Patients also display growth retardation, insulin resistance and glucose intolerance [6]. Carriers of the disease were found to die approximately 4 years earlier than non-carriers due to the development of cancer and approximately 11 years earlier due to ischemic heart disease [2,7].…”
Section: Introductionmentioning
confidence: 99%
“…Finally, although ATM is primarily localized to the nucleus, it has been shown that a minor fraction of the protein is present in the cytoplasm of various cell types [24]. First evidence for a cytoplasmic form is the discovery of ATM association with both peroxisomes and endosomes [25,26].…”
Section: Atm Kinase: Other Functionsmentioning
confidence: 99%